Hate needles? Well, an oral coronavirus vaccine in the works could become the best protection against COVID-19 and its mutations … that’s the hope of one of the L.A. Lakers owners, anyway.
Dr. Patrick Soon-Shiong is the founder of ImmunityBio as well as a Lakers co-owner, and his company is behind the tests being done at a research center in El Segundo, CA to determine if a series of pills can replace injections to inoculate the population.
Researchers are experimenting with healthy volunteers under the age of 55 who haven’t had COVID yet … with some getting shots, some getting capsules and some getting a combo.
Dr. Soon-Shiong says the value of ImmunityBio’s vaccine is that it generates “killer T cells” that target the center of the coronavirus, which is less prone to mutation. Current vaccines create antibodies to the spiky part of the virus on the surface.
Though researchers are hopeful the oral T-cell-creating approach may result in greater protection against COVID … the Lakers co-owner believes capsules and injections working together would be key. Sorry, needle haters.
It may still be a while before we find out, though — the oral vaccine is only in experimental stages, and test subjects will be closely monitored for the next 12 months.
'The Real Housewives of New Jersey' wasted no time bringing the drama in the Season… Read More
Getty Images Ed Sheeran chatted with “Extra’s” Melvin Robert ahead of his performance at the… Read More
Play video content Jake Updegraff Seeing David Archuleta's mother watch the music video for his… Read More
After spending much of the year in the hospital for an undisclosed medical issue, Kate… Read More
Getty Images Britney Spears thinks her mom Lynne is to blame for the drama surrounding… Read More
Play video content X / @baskstreetboys The Backstreet Boys are giving people ideas on how… Read More